awmsg logo

AWMSG appraisal process for a medicine for a rare disease

AWMSG reviewed its process for appraising orphan and ultra-orphan medicines and medicines developed specifically for rare diseases in July 2018. The process was updated in July 2019 to implement the recommendation from the review.

AWMSG appraisal process for a medicine for a rare disease

Cost-consequence analysis template

Clinician and Patient Involvement Group (CAPIG) information

CAPIG Terms of Reference